Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Vipoma 1Somatostatinoma 1Pheochromocytoma 1Neoplasms 1Neoplasm Metastasis 1Insulinoma 1Head and Neck Neoplasms 1Glucagonoma 1Gastrinoma 1Carcinoma, Medullary 1Carcinoma, Islet Cell 1Adenoma, Islet Cell 1

Interventions

Specimen Handling 2Radiotherapy 2Magnetic Resonance Spectroscopy 2tipifarnib 1pentetreotide 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1fostamatinib 1fluorodopa F 18 1fludarabine phosphate 1cabozantinib 1atezolizumab 1Tamoxifen 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Octreotide 1Nivolumab 1Molecular Diagnostic Techniques 1Ipilimumab 1Interleukin-13 1Indinavir 1Immunotherapy 1Genetic Testing 1Fluorodeoxyglucose F18 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Cryosurgery 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pheochromocytoma × Octreotide × Head & Neck × Clear all
NCT00466856 2012-05-18

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
10 enrolled
EndocrineHead & Neck

Vipoma, Glucagonoma, Head and Neck Neoplasms, Insulinoma, Adenoma, Islet Cell, Neoplasm Metastasis, Neoplasms, Pheochromocytoma, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡